A Potential Asset of Proteasome Inhibitor Singly or Combined with Cisplatin Provides Inhibitory Effect on Human Gastric Cancer Cells : Figure 3

Figure 3: The effect of ZLLFC combined with cisplatin at various concentrations for 72h on SGC-7901 cells viability. Group 4 was treated with cisplatin, group 5 was treated with cisplatin and 0.5 μmol/L ZLLFC, group 6 was treated with cisplatin and 1 μmol/L ZLLFC. * P<0.05 vs group 4.